Search
Close this search box.
Factor-H President is interviewed for the Rare Disease Advisor

Factor-H President is interviewed for the Rare Disease Advisor

On November 5th, Larry Luxner, journalist and senior correspondent for the Rare Disease Advisor network, interviewed Dr. Ignacio Muñoz-Sanjuan about Factor-H work in Latin America. Larry also spoke with Marina Kauffman who leads Factor-H work in Venezuela. In the accompanying podcast, Ignacio shares his journey from 2012 when he launched…
Factor-H hosts the US Premiere of two HD documentary films

Factor-H hosts the US Premiere of two HD documentary films

On November 07, 2024, Factor-H will host a fundraising event in Los Angeles to support our ongoing programs in Latin America.Factor-H is proud to present the US premiere for two documentary films about Huntington’s disease – The Light (The story of the Informal Caregivers for Huntington’s patients in Barranquitas, Venezuela, by Gindel…
Factor-H is Awarded the 2024 Amgen Prize!

Factor-H is Awarded the 2024 Amgen Prize!

Factor-H 'La Luz' Caregivers program wins the 2024 Amgen/MIT Solve award at the Concordia Summit We are extremely honored and humbled by this award, which will fund our caregivers support program in Venezuela. The prize money will be used to fund a caregivers’ training program, support out ongoing psychological and…
Factor-H nominated for the 2024 Amgen Prize

Factor-H nominated for the 2024 Amgen Prize

We are honored to be 1 of 5 finalist nonprofit organizations being nominated for this prestigious award, selected out of 90 applicant organizations. The award of US$150,000 will be given to one of the five finalists.  The Amgen Prize 2024 rewards innovative in rare disease patient care.  Factor-H submitted an…
HD in the News: EHDN March Newsletter

HD in the News: EHDN March Newsletter

In the recent EHDN Newsletter, Factor-H work is featured in two articles – the first launches the 2024 Gratitude Day campaign; the second is by Alex Fisher, who tells her story of coming to Venezuela and the work she is conducting together with Factor-H & Habitat LUZ in Maracaibo to…
Dr. Elena Cattaneo details in La Reppublica the cloning of the Huntington's disease gene & the social impact of the disease

Dr. Elena Cattaneo details in La Reppublica the cloning of the Huntington's disease gene & the social impact of the disease

Elena Cattaneo, leading scientist in HD research and a Senator for Life in Italy, has written this piece for the newspaper La Reppublica, detailing the identification of the cloning of the mutation that causes HD. Dr. Cattaneo is a consultant for Factor-H and a dear friend and supporter.  In this…
Gratitude Day - Video interviews from Spain

Gratitude Day - Video interviews from Spain

Ruth Blanco, president of the HD association in Spain & coordination of the European Huntington’s (EHA) program ‘Moving Forward‘ for Spain, conducted a series of interviews to support Factor-H Gratitude Day campaign. Ruth interviewed several scientists and family advocates from Europe, the USA and Venezuela, including Ignacio Muñoz-Sanjuán, to discuss…
Seminario del Dr. Muñoz-Sanjuán en la reunión de la sociedad de Neurología venezolana

Seminario del Dr. Muñoz-Sanjuán en la reunión de la sociedad de Neurología venezolana

Seminario del Dr. Ignacio Muñoz-Sanjuan, fundador de Factor-h, en la reunión anual de la sociedad venezolana de neurología, el 3 de junio 2023. Ignacio habla sobre programas terapéuticos actuales para la enfermedad de Huntington, comentando información actual de todos los programas sintomáticos y aquellos dirigidos a disminuir la expresión de…
Factor-H featured in the Moving Along magazine of the Movement Disorder Society

Factor-H featured in the Moving Along magazine of the Movement Disorder Society

The work Factor-H implements in Latin America is being recognized by the Movement Disorder Society, the main neurology association that deals with all aspects clinical and scientific with movement disorders. In their February 2023 issue of their magazine, Moving Along, Factor-H 2022 HD conference was highlighted. PLease take a look…
Meet Ignacio - a CRL interview

Meet Ignacio - a CRL interview

Meet our second disruptor Ignacio Muñoz-Sanjuán. Find out how Ignacio’s work is enabling organizations to develop novel therapies for Huntington’s disease. Through his drug discovery work at CHDI Foundation, a nonprofit organization, Ignacio fuels his motivation to uncover potential treatments and an eventual cure for this crippling transgenerational disease by…
EN